Sign in

CIK 0000914475

  • Large accelerated filer

NEUROCRINE BIOSCIENCES INC

Sign in to watch
Ticker
NBIX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330525145
Phone
+1 858-617-7600
Business address
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$3,162,347
in 4 filings, $3.2M under 10b5-1 plans

Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-10 Lloyd-Smith Malcolm Chief Regulatory Officer Option exercise · Non-Qualified Stock Option −1,700 $35.99 $61K 21,533
2021-02-08 ROBERTS EIRY Chief Medical Officer Grant or award · Stock Option +49,049 49,049
2021-02-08 Lloyd-Smith Malcolm Chief Regulatory Officer Grant or award · Stock Option +35,035 35,035
2021-02-08 Lippoldt Darin Chief Legal Officer Grant or award · Stock Option +45,546 45,546
2021-02-08 Grigoriadis Dimitri E. Chief Research Officer Grant or award · Stock Option +42,042 42,042
2021-02-08 GORMAN KEVIN CHARLES Chief Executive Officer Grant or award · Stock Option +113,863 113,863
2021-02-08 Gano Kyle Chief Business Development Off Grant or award · Stock Option +49,049 49,049
2021-02-08 Cooke Julie Chief Human Resources Officer Grant or award · Stock Option +35,035 35,035
2021-02-08 Bozigian Haig P. Chief Development Officer Grant or award · Stock Option +3,504 3,504
2021-02-08 BENEVICH ERIC Chief Commercial Officer Grant or award · Stock Option +49,049 49,049
2021-02-08 ABERNETHY MATT Chief Financial Officer Grant or award · Stock Option +49,049 49,049
2021-02-08 Gano Kyle Chief Business Development Off Sale −1,070 $116.89 $125K 102,406
2021-02-08 Gano Kyle Chief Business Development Off Sale −1,000 $116.83 $117K 103,306
2021-02-08 Gano Kyle Chief Business Development Off Sale −1,623 $116.83 $190K 104,768
2021-02-08 Gano Kyle Chief Business Development Off Grant or award · Stock Option +44,632 44,632
2021-02-08 Gano Kyle Chief Business Development Off Grant or award · Restricted Stock Unit +7,439 7,439
2021-02-08 ABERNETHY MATT Chief Financial Officer Sale −880 $116.85 $103K 13,043
2021-02-08 ABERNETHY MATT Chief Financial Officer Sale −2,030 $116.81 $237K 14,869
2021-02-08 ABERNETHY MATT Chief Financial Officer Grant or award · Stock Option +44,632 44,632
2021-02-08 ABERNETHY MATT Chief Financial Officer Grant or award · Restricted Stock Unit +7,439 7,439

Page 59 of 62 · 1,221 trades